Your browser doesn't support javascript.
loading
A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.
Lang, A-S; Mounier, M; Roques, M; Chretien, M L; Boulin, M.
Affiliation
  • Lang AS; Pharmacy Department, University Hospital, Dijon, France.
  • Mounier M; Hematological Malignancies Registry, Burgundy University, Dijon, France.
  • Roques M; Hematology Department, University Hospital, Dijon, France.
  • Chretien ML; Hematology Department, University Hospital, Dijon, France.
  • Boulin M; Pharmacy Department, University Hospital, Dijon, France.
J Clin Pharm Ther ; 40(4): 391-7, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25865674
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2015 Document type: Article Affiliation country: Francia Country of publication: Reino Unido